Yan ZL - Search Results

1

A novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy.

Huang LF, Xing X, Wu D, Xia Y, Li J, Wang K, Yan ZL, Wan XY, Shi LH, Yang T, Lau WY, Wu MC, Shen F. Huang LF, et al. Among authors: yan zl. Oncotarget. 2016 May 3;7(18):25493-506. doi: 10.18632/oncotarget.8333. Oncotarget. 2016. PMID: 27027439 Free PMC article.

2

[Injection of NKG5SV gene to inhibit growth and metastasis of hepatocellular carcinoma].

Sun J, Wu Z, Wu M, Shen F, Qian Q, He P, Yan Z, Cui Z, Xue H. Sun J, et al. Zhonghua Gan Zang Bing Za Zhi. 2002 Dec;10(6):421-5. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12502441 Chinese.

3

Relationship between the imaging features and pathologic alteration in hepatoma of rats.

Yang JH, You TG, Li N, Qian QJ, Wang P, Yan ZL, Wu MC. Yang JH, et al. Among authors: yan zl. World J Gastroenterol. 2003 Jan;9(1):69-72. doi: 10.3748/wjg.v9.i1.69. World J Gastroenterol. 2003. PMID: 12508354 Free PMC article.

4

[Role of post-operative transcatheter arterial chemoembolization in hepatocellular carcinoma with different pathological characteristics].

Xi T, Yan ZL, Wang K, Li J, Xia Y, Shen F, Wu MC. Xi T, et al. Among authors: yan zl. Zhonghua Wai Ke Za Zhi. 2007 May 1;45(9):587-90. Zhonghua Wai Ke Za Zhi. 2007. PMID: 17688789 Chinese.

5

Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation.

Lu ZH, Shen F, Yan ZL, Li J, Yang JH, Zong M, Shi LH, Wu MC. Lu ZH, et al. Among authors: yan zl. J Cancer Res Clin Oncol. 2009 Jun;135(6):783-9. doi: 10.1007/s00432-008-0513-0. Epub 2008 Nov 26. J Cancer Res Clin Oncol. 2009. PMID: 19034515

6

Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome.

Wang K, Liu J, Yan ZL, Li J, Shi LH, Cong WM, Xia Y, Zou QF, Xi T, Shen F, Wang HY, Wu MC. Wang K, et al. Among authors: yan zl. Hepatology. 2010 Jul;52(1):164-73. doi: 10.1002/hep.23650. Hepatology. 2010. PMID: 20578260

7

Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.

Xia Y, Qiu Y, Li J, Shi L, Wang K, Xi T, Shen F, Yan Z, Wu M. Xia Y, et al. Ann Surg Oncol. 2010 Dec;17(12):3137-44. doi: 10.1245/s10434-010-1148-3. Epub 2010 Jul 3. Ann Surg Oncol. 2010. PMID: 20602260 Clinical Trial.

8

[Clinical study of 169 patients with hepatic angiomyolipoma].

Yu F, Wang K, Yan ZL, Zhang XF, Li J, Dong H, Cong WM, Shi LH, Shen F, Wu MC. Yu F, et al. Among authors: yan zl. Zhonghua Wai Ke Za Zhi. 2010 Nov 1;48(21):1621-4. Zhonghua Wai Ke Za Zhi. 2010. PMID: 21211255 Chinese.

9

Sorafenib down-regulates c-IAP expression post-transcriptionally in hepatic carcinoma cells to suppress apoptosis.

Li XF, Gong RY, Wang M, Yan ZL, Yuan B, Wang K, Shi LH. Li XF, et al. Among authors: yan zl. Biochem Biophys Res Commun. 2012 Feb 17;418(3):531-6. doi: 10.1016/j.bbrc.2012.01.060. Epub 2012 Jan 21. Biochem Biophys Res Commun. 2012. PMID: 22285185

10

A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy.

Xia Y, Yan ZL, Xi T, Wang K, Li J, Shi LH, Wu MC, Shen F. Xia Y, et al. Among authors: yan zl. Hepatogastroenterology. 2012 Oct;59(119):2248-54. doi: 10.5754/hge11978. Hepatogastroenterology. 2012. PMID: 22366528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters